Ljubljana stock indices go down, NLB paces decliners
Podravka, HPB weigh on Croatian share indices
Most Bulgarian stock indices fall, SOFIX rises on Fibank gain
Most Romanian stock indices rebound, Electrica shines
Romania's Safetech Innovations net profit down 5% in 2023
Sep 17, 2009 17:16 EEST
September 17 (SeeNews) - Slovenian blue-chip pharmaceuticals company Krka said an Oslo appeals court has upheld a lower-court ruling in its favor in patent litigation over the manufacturing process of the Losartan drug in Norway.
The lower court had also awarded damages to the Slovenian drug maker.
"[Krka] received [on September 15] the decision of the Court of Appeal in Oslo, Norway in the dispute between the companies Merck & Co. Inc. and its affiliates Merck and Company, Incorporated, Merck Sharp & Dohme BV, MSD Norge A/S (hereinafter MSD) and Krka, d.d., Novo mesto and its affiliate Krka Sverige AB (hereinafter Krka), concerning an alleged infringement of a patent protecting production of losartan ingredient in Norway," the Slovenian company said in a filing with the Ljubljana Stock Exchange (LJSE) on Wednesday.
"The Court of Appeal confirmed the decision of the court of first instance that Krka does not infringe the stated patent. Based on the stated decision of the court of first instance MSD is obliged to restitute damages to KRKA arising out of the issued preliminary injunction prohibiting sales of Krka's products with losartan ingredient in Norway throughout the duration of the dispute, in the amount of NOK 30 million (approximately EUR 3.5 million) together with default interest and all costs of the proceedings in the amount of NOK 2.3 million (approximately EUR 267 thousand)," the statement said.
MSD can appeal against this judgement to the Supreme Court of Norway, Krka said.
Krka published the announcement considering the judgement of the court of first instance on June 26, 2008.
Losartan is used mainly to treat high blood pressure.
Shares in Krka were trading up 0.33% at an average price of 72.46 euro ($106.8) by 1118 GMT on Thursday on the LJSE.
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options